Barely Significant
← all excerpts

Rituximab for refractory rheumatoid arthritis: a 24-week open-label prospective study.

Open Rheumatol J · 2007 · PMC2581826 · PMID 19088893

Europe PMCDOI
1
hedged sentence
0.0900
closest p · 1.8× alpha
0.0900
boldest claim

The sentences

showed a trendp=0.09so close (0.05 < p ≤ 0.1)
The mean titers of anti-CCP also showed a trend of decrease (114 ± 103 to 105 ± 106 units; p=0.09).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.